![](https://endpts.com/wp-content/uploads/2024/05/Bob-Duggan-Summit-tile.jpg)
Bob Duggan, Summit Therapeutics CEO
Summit Therapeutics touts a rare triumph over Keytruda in lung cancer from a China-only Phase 3 study
Hours before America’s biggest cancer conference starts in Chicago, a small biotech may have stolen the show, touting late-stage results in a Thursday afternoon press …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.